Peripherally inserted concomitant surgical right and left ventricular support, the Propella, is associated with low rates of limb ischemia, with mortality comparable with peripheral venoarterial extracorporeal membrane oxygenation

Published:November 23, 2022DOI:



      Mechanical circulatory support effectively treats adult cardiogenic shock. Whereas cardiogenic shock confers high mortality, acute limb ischemia is a known complication of mechanical circulatory support that confers significant morbidity. We compared our novel approach to peripheral mechanical circulatory support with a conventional femoral approach, with a focus on the incidence of acute limb ischemia.


      This was a retrospective cohort study of patients treated with mechanical circulatory support between January 1, 2015 and December 5, 2021 at our institution. Patients receiving any femoral peripheral venoarterial extracorporeal membrane oxygenation were compared with those receiving minimally invasive, peripherally inserted, concomitant right and left ventricular assist devices. These included the Impella 5.0 (Abiomed, Danvers, MA) left ventricular assist device and the ProtekDuo (LivaNova, London, UK) right ventricular assist device used concomitantly (Propella) approach. The primary outcome was incidence of acute limb ischemia. The baseline patient characteristics, hemodynamic data, and post–mechanical circulatory support outcomes were collected. Fisher exact test and Wilcoxon rank sum test was used for the categorical and continuous variables, respectively. Kaplan-Meier curves and log-rank test were used to estimate overall survival probabilities and survival experience, respectively.


      Fifty patients were treated with mechanical circulatory support at our institution for cardiogenic shock, with 13 patients supported with the novel Propella strategy and 37 with peripheral venoarterial extracorporeal membrane oxygenation. The baseline characteristics, including patient organ function and medical comorbidities, were similar among the groups. Nine patients suffered mortality in ≤48 hours of mechanical circulatory support initiation and were excluded. Twenty patients (69%) suffered acute limb ischemia in the peripheral venoarterial extracorporeal membrane oxygenation group; 0 patients receiving Propella suffered acute limb ischemia (P < .001). The percentages of patients surviving to discharge in peripheral venoarterial extracorporeal membrane oxygenation and Propella groups were 24% and 69%, respectively (P = .007).


      Patients treated with the Propella experienced a lower incidence of acute limb ischemia compared with patients treated with peripheral venoarterial extracorporeal membrane oxygenation.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Reyentovich A.
        • Barghash M.H.
        • Hochman J.S.
        Management of refractory cardiogenic shock.
        Nat Rev Cardiol. 2016; 13: 481-492
        • Rihal C.S.
        • Naidu S.S.
        • Givertz M.M.
        • et al.
        2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care: endorsed by the American Heart Assocation, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; affirmation of value by the Canadian Association of Interventional Cardiology–Association Canadienne de Cardiologie d’intervention.
        J Am Coll Cardiol. 2015; 65: e7-e26
        • Sidebotham D.
        • McGeorge A.
        • McGuinness S.
        • Edwards M.
        • Willcox T.
        • Beca J.
        Extracorporeal membrane oxygenation for treating severe cardiac and respiratory disease in adults: part 1—overview of extracorporeal membrane oxygenation.
        J Cardiothorac Vasc Anesth. 2009; 23: 886-892
        • Cheng R.
        • Hachamovitch R.
        • Kittleson M.
        • et al.
        Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: a meta-analysis of 1,866 adult patients.
        Ann Thorac Surg. 2014; 97: 610-616
        • Aziz F.
        • Brehm C.E.
        • El-Banyosy A.
        • Han D.C.
        • Atnip R.G.
        • Reed A.B.
        Arterial complications in patients undergoing extracorporeal membrane oxygenation via femoral cannulation.
        Ann Vasc Surg. 2014; 28: 178-183
        • Stern J.R.
        • Wong C.K.
        • Yerovinkina M.
        • et al.
        A meta-analysis of long-term mortality and associated risk factors following lower extremity amputation.
        Ann Vasc Surg. 2017; 42: 322-327
        • Gulkarov I.
        • Bobka T.
        • Elmously A.
        • et al.
        The effect of acute limb ischemia on mortality in patients undergoing femoral venoarterial extracorporeal membrane oxygenation.
        Ann Vasc Surg. 2020; 62: 318-325
        • Cain M.T.
        • Smith N.J.
        • Barash M.
        • et al.
        Extracorporeal membrane oxygenation with right ventricular assist device for COVID-19 ARDS.
        J Surg Res. 2021; 264: 81-89
        • Vallabhajosyula S.
        • O’Horo J.C.
        • Antharam P.
        • et al.
        Venoarterial extracorporeal membrane oxygenation with concomitant impella versus venoarterial extracorporeal membrane oxygenation for cardiogenic shock.
        ASAIO J. 2020; 66: 497-503
        • Koponen T.
        • Karttunen J.
        • Musialowicz T.
        • Pietiläinen L.
        • Uusaro A.
        • Lahtinen P.
        Vasoactive-inotropic score and the prediction of morbidity and mortality after cardiac surgery.
        Br J Anesthes. 2019; 122: 428-436
        • Bonicolini E.
        • Martucci G.
        • Simons J.
        • et al.
        Limb ischemia in peripheral veno-arterial extracorporeal membrane oxygenation: a narrative review of incidence, prevention, monitoring, and treatment.
        Crit Care. 2019; 23: 266
        • Foley P.J.
        • Morris R.J.
        • Woo E.Y.
        • et al.
        Limb ischemia during femoral cannulation for cardiopulmonary support.
        J Vasc Surg. 2010; 52: 850-853
        • Tanaka D.
        • Hirose H.
        • Cavarocchi N.
        • Entwistle J.W.C.
        The impact of vascular complications on survival of patients on venoarterial extracorporeal membrane oxygenation.
        Ann Thorac Surg. 2016; 101: 1729-1734
        • Lamb K.M.
        • DiMuzio P.J.
        • Johnson A.
        • et al.
        Arterial protocol including prophylactic distal perfusion catheter decreases limb ischemia complications in patients undergoing extracorporeal membrane oxygenation.
        J Vasc Surg. 2017; 65: 1074-1079
        • Marbach J.A.
        • Faugno A.J.
        • Pacifici S.
        • et al.
        Strategies to reduce limb ischemia in peripheral venoarterial extracorporeal membrane oxygenation: a systematic review and Meta-analysis.
        Int J Cardiol. 2022; 361: 77-84
        • Kinlay S.
        Management of critical limb ischemia.
        Circulation. 2016; 9e001946
        • Rupprecht L.
        • Lunz D.
        • Philipp A.
        • Lubnow M.
        • Schmid C.
        Pitfalls in percutaneous ECMO cannulation.
        Heart Lung Vessel. 2015; 7: 320-326
        • Ricarte Bratti J.P.
        • Cavayas Y.A.
        • Noly P.E.
        • Serri K.
        • Lamarche Y.
        Modalities of left ventricle decompression during VA-ECMO therapy.
        Membranes (Basel). 2021; 11: 209
        • Batsides G.
        • Massaro J.
        • Cheung A.
        • Soltesz E.
        • Ramzy D.
        • Anderson M.B.
        Outcomes of Impella 5.0 in cardiogenic shock: a systematic review and meta-analysis.
        Innovations. 2018; 13: 254-260
        • Alharbi Anas A.
        • Alqahtani Fahad S.
        • Farjo P.
        • Moreland Jason A.
        Axillary artery pseudoaneurysm following percutaneous transaxillary access for impella device placement during percutaneous coronary intervention.
        JACC Case Rep. 2020; 2: 907-910
        • Kaki A.
        • Subahi A.
        • Shokr M.
        • et al.
        Impella-induced incessant ventricular tachycardia.
        Ochsner J. 2019; 19: 248
        • Oliveros E.
        • Collado F.M.
        • Poulin M.F.
        • Seder C.W.
        • March R.
        • Kavinsky C.J.
        Percutaneous right ventricular assist device using the TandemHeart ProtekDuo: real-world experience.
        J Invasive Cardil. 2021; 33: E407-E411
        • Sef D.
        • Kabir T.
        • Lees N.J.
        • Stock U.
        Valvular complications following the Impella device implantation.
        J Card Surg. 2021; 36: 1062-1066
        • Hassett C.E.
        • Cho S.-M.
        • Hasan S.
        • et al.
        Ischemic stroke and intracranial hemorrhages during impella cardiac support.
        ASAIO J. 2020; 66: e105-e109
        • Stulak J.M.
        • Dearani J.A.
        • Burkhart H.M.
        • Barnes R.D.
        • Scott P.D.
        • Schears G.J.
        ECMO cannulation controversies and complications.
        Semin Cardiothorac Vasc Anesth. 2009; 13: 176-182
        • Ghodsizad A.
        • Koerner M.M.
        • Brehm C.E.
        • El-Banayosy A.
        The role of extracorporeal membrane oxygenation circulatory support in the ‘crash and burn’ patient: from implantation to weaning.
        Curr Opin Cardiol. 2014; 29: 275-280
        • Livesey M.
        • Jauregui J.J.
        • Hamaker M.C.
        • Pensy R.A.
        • Langhammer C.G.
        • Eglseder W.A.
        Management of vasopressor induced ischemia.
        J Orthop. 2020; 22: 497-502
        • Vallabhajosyula S.
        • Ya’Qoub L.
        • Singh M.
        • et al.
        Sex disparities in the management and outcomes of cardiogenic shock complicating acute myocardial infarction in the young.
        Circ Heart Fail. 2020; 13e007154
        • Gulati R.
        • Behfar A.
        • Narula J.
        • et al.
        Acute myocardial infarction in young individuals.
        Mayo Clinic Prov. 2020; 95: 136-156
        • Fronek A.
        • Criqui M.H.
        • Denenberg J.
        • Langer R.D.
        Common femoral vein dimensions and hemodynamics including Valsalva response as a function of sex, age, and ethnicity in a population study.
        J Vasc Surg. 2001; 33: 1050-1056
        • Parissis H.
        • Soo A.
        • Leotsinidis M.
        • Dougenis D.
        A statistical model that predicts the length from the left subclavian artery to the celiac axis; towards accurate intra aortic balloon sizing.
        J Cardiothorac Surg. 2011; 6: 95
        • Nelson D.W.
        • Sundararajan S.
        • Klein E.
        • et al.
        Sustained use of the Impella 5.0 heart pump enables bridge to clinical decisions in 34 patients.
        Texas Heart Inst J. 2021; 48e207260
        • Chamogeorgakis T.
        • Rafael A.
        • Shafii A.E.
        • Nagpal D.
        • Pokersnik J.A.
        • Gonzalez-Stawinski G.V.
        Which is better: a miniaturized percutaneous ventricular assist device or extracorporeal membrane oxygenation for patients with cardiogenic shock?.
        ASAIO J. 2013; 59: 607-611
        • Al-Thani H.
        • Sathian B.
        • El-Menyar A.
        Assessment of healthcare costs of amputation and prosthesis for upper and lower extremities in a Qatari healthcare institution: a retrospective cohort study.
        BMJ Open. 2019; 9e024963
        • MacKenzie E.J.
        • Castillo R.C.
        • Jones A.S.
        • et al.
        Health-care costs associated with amputation or reconstruction of a limb-threatening injury.
        J Bone Joint Surg Am. 2007; 89: 1685-1692